Xeris Biopharma Holdings Inc Live Share Price Today, Share Analysis and Chart

Name: Xeris Biopharma Holdings Inc: Is Infosys Ltd. worth buying?
Item: Xeris Biopharma Holdings Inc
Rating: 2.05825
Author: Trendlyne DVM scores

about

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrom...

5.24 -0.20 (-3.68%)

149.52% Gain from 52W Low

1.2M

XNAS Volume

XNAS 15 Jul, 2025 3:22 PM (EDT)

Not Eligible

Expensive Valuation

10.5 / 100

Technically Bullish

71.8 / 100

1Yr Price target upside is 20%

5 analysts

Xeris Biopharma Holdings Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Xeris Biopharma Holdings Inc Live Share Price Today, Share Analysis and Chart

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrom...

149.52% Gain from 52W Low

SWOT Analysis

Xeris Biopharma Holdings Inc Live Price Chart